BACKGROUND AND PURPOSE: Hepatic encephalopathy in cirrhotic patients may be the clinical manifestation of disturbed cerebral cell volume homeostasis. The aim of this study was to investigate the presence of significant changes in magnetization transfer ratio (MTR) values, which could reflect an increase in free water within the brain of patients with liver cirrhosis, and to correlate these findings with minimal hepatic encephalopathy and proton MR spectroscopy ((1)H-MRS) abnormalities. METHODS: Twenty-four patients with liver cirrhosis and eight healthy control volunteers were included in the study. MR imaging studies included conventional T1- and T2-weighted imaging, (1)H-MRS, and magnetization transfer imaging. MTR and (1)H-MRS values were obtained from normal-appearing white matter and were correlated with each other and with the presence of minimal hepatic encephalopathy. RESULTS: (1)H-MRS showed a decrease in choline and myo-inositol and an increase in glutamine + glutamate with respect to creatine + phosphocreatine. MTR values were significantly decreased in cirrhotic patients when compared with healthy control volunteers, although this decrease was not significantly higher in the patients with minimal hepatic encephalopathy. The decreases in MTR values correlated with increases in glutamine + glutamate. CONCLUSION: The MTR decrease in patients with liver cirrhosis may be caused by low-grade astrocytic swelling produced as a response to the osmotic stress occurring in these patients. However, in this cross-sectional study, we did not find a correlation between MTR decrease and the presence of minimal hepatic encephalopathy, probably because of limitations in MTR quantification techniques.
BACKGROUND AND PURPOSE:Hepatic encephalopathy in cirrhoticpatients may be the clinical manifestation of disturbed cerebral cell volume homeostasis. The aim of this study was to investigate the presence of significant changes in magnetization transfer ratio (MTR) values, which could reflect an increase in free water within the brain of patients with liver cirrhosis, and to correlate these findings with minimal hepatic encephalopathy and proton MR spectroscopy ((1)H-MRS) abnormalities. METHODS: Twenty-four patients with liver cirrhosis and eight healthy control volunteers were included in the study. MR imaging studies included conventional T1- and T2-weighted imaging, (1)H-MRS, and magnetization transfer imaging. MTR and (1)H-MRS values were obtained from normal-appearing white matter and were correlated with each other and with the presence of minimal hepatic encephalopathy. RESULTS: (1)H-MRS showed a decrease in choline and myo-inositol and an increase in glutamine + glutamate with respect to creatine + phosphocreatine. MTR values were significantly decreased in cirrhoticpatients when compared with healthy control volunteers, although this decrease was not significantly higher in the patients with minimal hepatic encephalopathy. The decreases in MTR values correlated with increases in glutamine + glutamate. CONCLUSION: The MTR decrease in patients with liver cirrhosis may be caused by low-grade astrocytic swelling produced as a response to the osmotic stress occurring in these patients. However, in this cross-sectional study, we did not find a correlation between MTR decrease and the presence of minimal hepatic encephalopathy, probably because of limitations in MTR quantification techniques.
Authors: C Rose; R F Butterworth; J Zayed; L Normandin; K Todd; A Michalak; L Spahr; P M Huet; G Pomier-Layrargues Journal: Gastroenterology Date: 1999-09 Impact factor: 22.682
Authors: D Häussinger; J Laubenberger; S vom Dahl; T Ernst; S Bayer; M Langer; W Gerok; J Hennig Journal: Gastroenterology Date: 1994-11 Impact factor: 22.682
Authors: J F Hiehle; R E Lenkinski; R I Grossman; V Dousset; K N Ramer; M D Schnall; J A Cohen; F Gonzalez-Scarano Journal: Magn Reson Med Date: 1994-09 Impact factor: 4.668
Authors: Hui Juan Chen; Gang Zheng; Julian L Wichmann; U Joseph Schoepf; Guang Ming Lu; Long Jiang Zhang Journal: Metab Brain Dis Date: 2015-09-24 Impact factor: 3.584
Authors: Vijay P B Grover; Joshua M Tognarelli; Mary M E Crossey; I Jane Cox; Simon D Taylor-Robinson; Mark J W McPhail Journal: J Clin Exp Hepatol Date: 2015-08-20
Authors: Vijay P B Grover; Mary M E Crossey; Julie A Fitzpatrick; Brian K Saxby; Roberta Shaw; Adam D Waldman; Marsha Y Morgan; Simon D Taylor-Robinson Journal: Metab Brain Dis Date: 2015-08-08 Impact factor: 3.584
Authors: Karin Weissenborn; Martin Bokemeyer; Björn Ahl; Daniela Fischer-Wasels; Kathrin Giewekemeyer; Jörg van den Hoff; Herbert Köstler; Georg Berding Journal: Metab Brain Dis Date: 2004-12 Impact factor: 3.584
Authors: F Miese; G Kircheis; H J Wittsack; F Wenserski; J Hemker; U Mödder; D Häussinger; M Cohnen Journal: AJNR Am J Neuroradiol Date: 2006-05 Impact factor: 3.825
Authors: René C W Mandl; Hugo G Schnack; Judy Luigjes; Martijn P van den Heuvel; Wiepke Cahn; René S Kahn; Hilleke E Hulshoff Pol Journal: Schizophr Bull Date: 2008-11-27 Impact factor: 9.306